Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
HSCT for High Risk Inherited Inborn Errors
This study is currently recruiting participants.
Study NCT00383448 Information provided by Masonic Cancer Center, University of Minnesota
First Received: September 29, 2006 Last Updated: July 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Adrenoleukodystrophy
Metachromatic Leukodystrophy
Globoid Cell Leukodystrophy
Tay Sachs Disease
Sandhoffs Disease
I-Cell Disease
Sanfillipo
GM1 Gangliosidosis
Additional conditions recognized in this trial
Addison Disease
Gangliosidoses
Gangliosidosis, GM1
Leukodystrophy, Globoid Cell
Leukodystrophy, Metachromatic
Mucolipidoses
Sandhoff Disease
Tay-Sachs Disease
More general conditions related to this trial
Adrenal Gland Diseases
Adrenal Insufficiency
Autoimmune Diseases
Bone Diseases
Bone Diseases, Metabolic
Brain Diseases
Brain Diseases, Metabolic
Brain Diseases, Metabolic, Inborn
Carbohydrate Metabolism, Inborn Errors
Central Nervous System Diseases
Demyelinating Diseases
Endocrine System Diseases
Gangliosidoses, GM2
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Hereditary Central Nervous System Demyelinating Diseases
Heredodegenerative Disorders, Nervous System
Immune System Diseases
Lipid Metabolism Disorders
Lipid Metabolism, Inborn Errors
Lipidoses
Lysosomal Storage Diseases
Lysosomal Storage Diseases, Nervous System
Mental Retardation
Mental Retardation, X-Linked
Metabolic Diseases
Metabolism, Inborn Errors
Musculoskeletal Diseases
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Peroxisomal Disorders
Sphingolipidoses
Sulfatidosis
Interventions listed in this trial
Campath
Clofarabine
Total body Irradiation
Melphalan
Additional drug interventions recognized in this trial
Alemtuzumab
More general drug interventions related to this trial
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Masonic Cancer Center, University of Minnesota
Back to top of Main Content
